FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely ophthalmology, and involves use of suspended cultivated neuronal self-cells precipitated from olfactory region of nasal mucosa, or cultivated mesenchymal self-cells precipitated from bone marrow. Stem cells are introduced suprachoroidally in amount 500 thousand per 0.02 ml of physiologic saline or retrobulbary 1.5 million per 0.3 ml of physiologic saline. The introduction is repeated 20-30 days later.
EFFECT: method allows for prolonged and adequate improvement of capacity and reparative activity of retina with various pathologies.
2 cl, 6 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR IMPROVING FUNCTIONAL RETINA ACTIVITY IN THE CASES OF ITS ABNORMALITY OF VARIOUS GENESIS | 2004 |
|
RU2279886C2 |
| METHOD FOR CORRECTING DYSTROPHIC CHANGES IN RETINA IN PATHOLOGIC CASES OF VARIOUS GENESIS | 2003 |
|
RU2238705C1 |
| METHOD OF SIMULATING RETINAL PIGMENT EPITHELIUM ATROPHY | 2019 |
|
RU2727000C1 |
| METHOD TO TREAT "DRY" FORM OF AGE MACULAR DEGENERATION | 2007 |
|
RU2333737C1 |
| METHOD OF TREATING "DRY" FORM OF AGE-SPECIFIC MACULAR DEGENERATION | 2011 |
|
RU2470619C1 |
| METHOD FOR ESTIMATING RETINA FUNCTIONS | 2005 |
|
RU2284743C1 |
| METHOD OF SUBRETINAL TRANSPLANTATION OF RETINAL PIGMENT EPITHELIUM (RPE) CELLS DIFFERENTIATED FROM HUMAN INDUCED PLURIPOTENT STEM CELLS, WITH ATROPHY OF RETINAL PIGMENT EPITHELIUM IN EXPERIMENT | 2019 |
|
RU2729937C1 |
| METHOD FOR MODELING ISCHEMIA RETINAE | 2006 |
|
RU2313312C1 |
| METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
| METHOD FOR MODELING TOXIC RETINOPATHY | 2004 |
|
RU2284582C2 |
